Healthtech Startups

CINI is a non-profit organization in India focused on child health and development, with leadership drawn from medical, administrative, and social sectors.

1 investor

CINV is a pharmaceutical-grade botanical therapeutics platform that cultivates, processes, and distributes regulated plant-derived medicines and standardised APIs, with medical cannabis (CBPMs) as its core product. It operates a vertically integrated seed-to-patient supply chain and clinical research program, serving patients through licensed distribution partners across the UK and Europe.

1 investor

Cipla Health is a consumer healthcare subsidiary that sells branded over-the-counter health products including throat lozenges, cough remedies, probiotics, oral care, and wellness supplements. The company targets consumers seeking relief from common ailments and daily health support.

1 investor

CIPRA.ai develops an AI-based platform for precise diagnosis and management of chronic conditions including hypertension and diabetes for patients and health systems. The platform uses data-driven approaches to identify relationships between lifestyle factors and chronic disease outcomes.

1 investor

Circada develops circadian lighting products and systems that adjust light intensity, color, and wavelengths to align with the natural progression of the sun, aiming to support the body's circadian rhythm and health outcomes. The company also conducts research in clinical settings such as intensive care patient recovery and neuro-rehabilitation.

1 investor

Circadian Health provides virtual access to cardiology, pulmonology, endocrinology, and sleep specialist care supported by home monitoring and diagnostic tools. The company serves patients with chronic conditions seeking remote specialist consultations.

1 investor

Circadian Positioning Systems develops circadian rhythm-based solutions aimed at optimizing human performance in mission-critical scenarios.

1 investor

Circadiance develops and manufactures remote patient monitoring products with cloud-based solutions that connect healthcare professionals to patients, including tools that help premature infants leave the hospital sooner. It also makes PAP and non-invasive ventilation products for people with sleep-disordered breathing and NICU patients, serving hospitals and homecare companies.

1 investor

Circe Scientific provides DMPK (drug metabolism and pharmacokinetics) and PK/PD consulting for biotech, pharmaceutical, and venture capital clients working in drug discovery and development. It supports research projects across inhaled, dermal, and oral drug delivery routes.

1 investor

Circle Cardiovascular Imaging is a Canadian software company that develops AI-powered solutions for analyzing medical imaging data, specifically focusing on cardiovascular imaging to support clinical decision-making and improve patient care outcomes.

1 investor

1 investor

Circulate Health provides therapeutic plasma exchange (TPE) treatments for longevity care, offering science-based clinical interventions to extend healthspan. The company enables clinics to deliver TPE services to patients and conducts research to advance the clinical evidence base for longevity medicine.

1 investor

Circumvent develops precision medicines for neurodegenerative diseases, with current focus on Batten Disease and other rare neurological disorders. The company's research targets synaptic dysfunction and lysosomal pathways through investigation of the palmitoylome.

1 investor

MLM Medical Labs (which acquired CirQuest Labs) provides central and specialty laboratory services for global clinical trials, including clinical testing, biomarker assay development, clinical trial kit building, sample analysis, and biological sample storage. It serves biotech and pharmaceutical companies developing drugs, operating central labs in Germany and Memphis, Tennessee.

1 investor

Cirrus Therapeutics is a biotech developing gene and cell therapies based on ocular immunology to treat dry age-related macular degeneration (AMD), including an AAV gene therapy to restore the IRAK-M immune regulator and a next-generation retinal pigment epithelium (RPE) cell therapy for advanced geographic atrophy. It serves patients with chronic blinding eye diseases and operates from Cambridge, Massachusetts and Singapore.

1 investor

Cisterna Biologics develops yeast-engineered mRNA manufacturing technology that can be selectively purified to drive protein expression in human cells. The company targets cost-effective, scalable, and non-immunogenic mRNA production for therapeutic applications.

1 investor

Citrus Health Group is a healthcare communications agency that provides scientific, clinical, and commercialization support to biopharmaceutical companies bringing new assets to market. It offers services including medical communications, commercialization strategy, market access, and launch planning across therapeutic areas such as oncology and rare diseases.

1 investor

1 investor

HAVEN is an indoor air quality solutions platform for homes in North America that provides HVAC professionals with tools to diagnose and manage air quality issues for homeowners.

1 investor

Claim Health provides revenue operations software for home-based care agencies, automating claims management, authorization tracking, and financial visibility to reduce claim denials and administrative overhead.

1 investor

ClaimGlide develops AI-powered software that automates the prior authorization process for healthcare providers, handling creation, submission, follow-up, and appeals to increase approval rates and reduce manual work.

1 investor

Clara is an AI-powered primary care practice that pairs licensed clinicians with artificial intelligence to deliver personalized, proactive healthcare through virtual visits and secure messaging. The company serves patients seeking primary care and is based in San Francisco.

1 investor

Clara Health operates a decentralized clinical trial platform that connects patients with clinical studies and provides 24/7 patient navigators to guide them through matching, scheduling, insurance, and paperwork at no cost. It also helps trial sponsors reach diverse and representative patient populations beyond physical trial sites; the company has been acquired by clinical research organization M&B Sciences Inc.

1 investor

ClaraPrice provides a compliance platform and expert services that help hospitals meet CMS Hospital Price Transparency requirements and the No Surprises Act. Its offerings cover machine-readable and shoppable-services pricing files, Good Faith Estimates, and payer contract management for hospitals across the United States.

1 investor